Skip to main content

Headlines

Larimar Therapeutics Names John Harlow As President And COO
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Eli Lilly Stock Barely Moved Following Viking Therapeutics' Impressive Clinical Results. Here's Why.
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Unicycive Therapeutics Resubmits Oxylanthanum Carbonate NDA To FDA
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Kyowa Kirin, Knight Therapeutics Enter Distribution Deal For POTELIGEO In Latin America
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Decoy Therapeutics Reports Preclinical Data For Weekly Intranasal DCOY-CoV
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
CRISPR Therapeutics Has 2 Key Catalysts Coming by the End of 2026. Is the Market Underestimating Them?
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Egetis Therapeutics' EMCITATE Wins FDA Approval For MCT8 Deficiency
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Summit Therapeutics Jumps on $2 Billion AstraZeneca Deal
posted:
by: Bloomberg Daybreak
#channels:: #All, #Business, #Bloomberg, #BloombergDaybreak, #Stocks
August 2027 Options Now Available For Halozyme Therapeutics (HALO)
posted:
by: Nasdaq Options
#channels:: #All, #Business, #Stocks, #Nasdaq, #Options, #StockOptions, #NasdaqOptions
Merck Signs $2.13 Bln License Deal With SciBrunch Therapeutics For KRAS G12D Inhibitor
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Addex Therapeutics H1 Net Loss Widens, Operating Loss Narrows; Advances GABAB PAM Cough Program
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Why Summit Therapeutics Stock Is Sinking Today
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Sarepta Therapeutics Enters Oversold Territory (SRPT)
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?
posted:
by: Nasdaq Technology
#channels:: #All, #Business, #Nasdaq, #Technology, #NasdaqTechnology, #Stocks
If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META